The Use of ‘Live Chemical Imaging’ to Enhance and Increase Productivity in SEM/EDS Investigation of Pharmaceutical Samples, While Still Conforming to 21 CFR Part 11 Regulations

Anthony Hyde; Simon Burgess; Jenny Goulden

doi:10.1017/S1431927619007116

The Use of ‘Live Chemical Imaging’ to Enhance and Increase Productivity in SEM/EDS Investigation of Pharmaceutical Samples, While Still Conforming to 21 CFR Part 11 Regulations

Published online by Cambridge University Press: 05 August 2019

Anthony Hyde ,

Simon Burgess and

Jenny Goulden

Show author details

Anthony Hyde: Affiliation:
Oxford Instruments, High Wycombe, United Kingdom
Simon Burgess: Affiliation:
Oxford Instruments, High Wycombe, United Kingdom
Jenny Goulden: Affiliation:
Oxford Instruments, High Wycombe, United Kingdom

Article contents

Abstract
References

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Type: Pharmaceuticals FIG – Imaging, Analysis, and Regulation of Medical Products, Devices and Data Integrity
Information: Microscopy and Microanalysis , Volume 25 , Supplement S2 , August 2019 , pp. 1276 - 1277

DOI: https://doi.org/10.1017/S1431927619007116 [Opens in a new window]

References

[1]FDA (https://www.fda.gov/downloads/regulatoryinformation/guidances/ucm125125.pdf)Google Scholar

Article contents

The Use of ‘Live Chemical Imaging’ to Enhance and Increase Productivity in SEM/EDS Investigation of Pharmaceutical Samples, While Still Conforming to 21 CFR Part 11 Regulations

Abstract

References

Save article to Kindle

Save article to Dropbox

Save article to Google Drive

Reply to: Submit a response

Your details

You have entered the maximum number of contributors

Conflicting interests